Nuo Therapeutics AURX
OTC AURX
$1.29 +0.03 (+2.46%)
As of: Oct 21, 2026 · 12:22 PM EDT

Nuo Therapeutics (AURX) EV to EBITDA (2021)

Updated

Nuo Therapeutics' (AURX) EV to EBITDA stood at -61.13 in Q4 2021.

Analysis

Nuo Therapeutics (AURX) EV to EBITDA (2021) Analysis & Trends

On a TTM basis, Nuo Therapeutics' EV to EBITDA came in at -199.03 as of Dec 31, 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 254.31 Bn 233.34 Bn 4.88 Bn
2 Abbott Laboratories 176.98 Bn 147.41 Bn 7.27 Bn
3 Danaher 164.79 Bn 148.60 Bn 3.61 Bn
4 Intuitive Surgical 155.89 Bn 135.31 Bn 1.96 Bn
5 Medtronic 122.92 Bn 88.18 Bn 6.34 Bn
6 Stryker 118.26 Bn 104.38 Bn 4.50 Bn
7 Boston Scientific 67.03 Bn 61.80 Bn 3.85 Bn
8 Becton Dickinson 54.67 Bn 51.82 Bn 2.32 Bn
9 Edwards Lifesciences 51.63 Bn 35.63 Bn 1.35 Bn
10 Nuo Therapeutics 61.03 Mn 59.20 Mn 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -3.12
Sep 30, 2021 8.71
API Access

Nuo Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=AURX&period=max&api_key=YOUR_API_KEY